Places are extremely limited for both our Boston and Dublin events and are exclusively available to HealthXL members only. These events will not be streamed, recorded or shared - rather they are special member only events. Our events are collaborative in nature - there will be no keynote speakers, but rather a coming together of like-minded people to discuss & innovate the future of digital health.
We will explore precision digital therapeutics over two 90-minute sessions (Morning and Afternoon) with a break in-between for a networking lunch. In order to facilitate collaboration and shared insights with your peers, our event will be roundtable based (8 per table) with each table being afforded the opportunity to present their findings.
Patients with a given condition are heterogenous where some drugs work better for different patients over others. The same will hold true for DTx solutions within a given condition. Understanding what DTx will work in a particular group of patients and how to make those decisions efficiently will be critical for DTx success in a broader population. What do we need to do now to realise this?
Choosing the best combination of drug and DTx for a given patient will by its nature require brand-agnostic DTx solutions and the ability for patients to either change drugs and retain their DTx or vice versa. While this will involve many more stakeholders than just pharma and DTx developers, we want to start the discussion with this group.
Our new exclusive and limited members package includes:
Plus, an exclusive invite to our upcoming in-person events taking place in Boston and Dublin this October.